LGT Capital Partners Joins Montagu and Astorg as Shareholder in Global Drug Delivery Leader Nemera

LGT Capital Partners Joins Montagu and Astorg as Shareholder in Global Drug Delivery Leader Nemera

(IN BRIEF) Montagu and Astorg have welcomed LGT Capital Partners as a new minority shareholder in Nemera, a global leader in drug delivery devices. Montagu and Astorg will remain majority shareholders while partnering with LGT CP to drive Nemera’s next growth phase. Headquartered across seven global manufacturing sites, Nemera serves the pharmaceutical, biotech, and generics markets with end-to-end solutions for auto-injectors, pens, inhalers, and other advanced devices. Backed by Montagu and Astorg since 2019, Nemera has achieved substantial growth, expanded its market presence, and reinforced its innovation capabilities. LGT CP’s investment will support further expansion of proprietary products, manufacturing capacity, and global reach, with all three shareholders committed to accelerating Nemera’s strategic vision.

(PRESS RELEASE) LONDON, 13-Aug-2025 — /EuropaWire/ — Montagu and Astorg, two leading private equity firms, have welcomed LGT Capital Partners (LGT CP) as a new minority shareholder in Nemera, a global leader in drug delivery device manufacturing. Montagu and Astorg will remain majority shareholders and continue supporting Nemera’s strategic growth, with LGT CP joining to strengthen the company’s next phase of expansion.

Nemera designs, develops, and manufactures a comprehensive portfolio of drug delivery devices, including auto-injectors, pens, inhalers, preservative-free multi-dose eye droppers, and pumps. Operating from seven advanced manufacturing sites in France, the US, Germany, Poland, and Brazil, the company serves pharmaceutical, biotech, and generic drug manufacturers worldwide. Nemera provides end-to-end solutions from initial design to high-volume production, delivering innovative and reliable products that enhance treatment outcomes and patient experience.

Over the past six years, with Montagu and Astorg’s backing, Nemera has significantly scaled its operations, broadened its customer base, and reinforced its market position in high-growth drug delivery segments. The addition of LGT CP is expected to accelerate investments in innovation, manufacturing capacity, and global expansion, with a focus on strengthening proprietary product lines, enhancing operational excellence, and expanding service capabilities.

Héloïse Pujolle, Partner at Montagu, commented: “We are delighted to welcome LGT CP as a shareholder in Nemera. Since our re-investment in 2019, the company has delivered impressive growth, extended its global reach, and cemented its leadership in the sector. This transaction reinforces our confidence in Nemera’s strategy and management team.”

Nicolas Marien, Partner at Astorg, added: “Nemera has significantly grown during our partnership, backed by a robust innovation pipeline and a truly global footprint. We are proud of what we’ve achieved together and look forward to working with LGT CP to further accelerate Nemera’s growth.”

Andreas Hellmann, Partner at LGT Capital Partners, said: “We have followed Nemera for years and have been impressed by its leadership, commitment to innovation, and focus on improving patients’ lives. We are excited to support the management team and existing shareholders as the company continues to expand globally and deliver advanced solutions to partners and patients.”

Media enquiries – Montagu

Greenbrook: James Madsen, Cecilie Oerting

+44 20 7952 2000 | montagu@greenbrookadvisory.com

Media enquiries – Astorg

Samia Hadj, Head of Corporate Communications

shadj@astorg.com / +33 7 88 34 43 99

Prosek Partners: pro-astorg@prosek.com

Media enquiries – LGT Capital Partners

Sebastian Kistner, Head of Corporate Communications

sebastian.kistner@lgtcp.com, +41 79 777 52 62

About Montagu

Montagu is a leading mid-market private equity firm, committed to finding and growing businesses that make the world work. Focussing on businesses with a must-have product or service in a structurally growing marketplace, Montagu brings proven growth capabilities to help companies achieve their ambitions and unlock their full potential. Montagu specialises in carve-out and other first time buyout investments and has deep expertise in five priority sectors: Healthcare, Financial Sector Services, Critical Data, Digital Infrastructure and Education. ESG forms an integral part of its strategy, and its commitment to responsible investment is fully integrated into its investment and value-creation process.

For additional information on Montagu, visit www.montagu.com

About Astorg

Astorg is a leading pan-European private equity firm with over €23 billion of assets under management. Astorg works with entrepreneurs and management teams to acquire market leading international companies headquartered in Europe or the US, providing them with the strategic guidance, governance and capital they need to achieve their growth goals. Enjoying a distinct entrepreneurial culture, a long-term shareholder perspective and a lean decision making body, Astorg has valuable industry expertise in healthcare, technology & software, and business services companies. Headquartered in Luxembourg, Astorg has offices in London, Paris, New York, Frankfurt and Milan. For more information about Astorg: www.astorg.com | Follow Astorg on LinkedIn.

About LGT Capital Partners

LGT Capital Partners is a leading global specialist in alternative investing with over USD 100 billion in assets under management and more than 700 institutional clients in 50 countries. An international team of over 900 professionals is responsible for managing a wide range of investment programs focusing on private markets, multi-alternatives and diversifying strategies, as well as sustainable and impact strategies. Headquartered in Pfaeffikon (SZ), Switzerland, the firm has offices in San Francisco, New York, Dublin, London, Paris, The Hague, Luxembourg, Frankfurt am Main, Vaduz, Dubai, Beijing, Hong Kong, Tokyo, Singapore and Sydney.

SOURCE: Montagu Private Equity